Along this line of thought, Yuan et al. (2017) found that BNIP3L/NIX is involved in mitochondrial autophagy induced by cerebral ischemia-reperfusion, suggesting that BNIP3L may be a new therapeutic target for ischemic stroke management. The gene discussed is BNIP3L; the disease is Cerebral ischemia.